Olin Corporation (OLN) | The Buildout — AI Infrastructure
The Verdict
Olin Corporation manufactures chlorine, caustic soda, vinyls, epoxy resins, and Winchester ammunition. It does not sell into AI infrastructure directly; the only disclosed AI use is internal plant reliability and efficiency. Any AI-adjacent exposure is inferred through electronic-grade epoxy formulations and semiconductor-adjacent end markets.
| Market Cap | — |
| Revenue (TTM) | $6.7B |
| Revenue Growth | +0.6% |
| EBITDA Margin (TTM) | 6.6% |
| Net Debt | $3.2B |
| Earnings Beats | 5 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Q2 2026 adjusted EBITDA reached $191.3 million, near the top of management's $160–200 million guidance.
- Epoxy posted its best result in more than three years; structural cost reductions from Stade and Guarulhos now exceed $50 million per year.
- Beyond250 targets more than $250 million in cumulative savings by 2028, with 2026 savings expected above $100 million.
- Announced Huntsman merger of equals would create a company with more than $12 billion in combined sales and $400 million in stated synergies.
- Winchester faces roughly 20% tariffs on imported ammunition, which management calls a tailwind for the commercial business.
What We’re Watching
- Q3 2026 adjusted EBITDA guidance of $100–200 million implies a possible sequential step-down from Q2's $191.3 million.
- Freeport VCM is expected to regain full capacity by end of Q3 2026; Q4 recovery depends on completing repairs.
- Huntsman shareholder vote is August 25, 2026; deal close is expected first half of 2027.
- Year-end leverage is guided to roughly 4.5x, with about $195 million in legacy Shintech payments due in 2026.
The operating thesis is intact but conditional. Q2 delivered near the top of guidance and epoxy inflected, but management frames Q3 as normalization and underlying housing and automotive demand is stable, not recovering. The open question is whether Q4 chemical tightening materializes or the conflict-driven price spike simply unwinds.
Earnings Beat
Q2 2026 revenue was $1,741.9 million, with gross margin of 9.8%. Reported net loss was ($13.3) million, while adjusted EBITDA reached $191.3 million, near the top of management's $160–200 million guidance.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $1.7B | $1.6B | $1.8B | −0.9% |
| Gross margin | 9.8% | 5.0% | 7.9% | +190bps |
| EBITDA | $190M | $57M | $165M | +14.8% |
| EPS | $-0.12 | $-0.73 | $-0.01 | +942.0% |
During the second quarter, our epoxy business posted its best results in more than 3 years.— Ken Lane, CEO, July 31, 2026
Management tone: Management's tone improved from the Q4 2025 call's caution to the Q1 2026 call's 'well positioned' framing, then turned careful again on Q2. On Q2, management accepted the strong result but refused to extrapolate, framing Q3 as normalization and attributing the wide range to volatile export pricing, FIFO costs, and outage effects.
Management Guidance
Management provided no annual EBITDA outlook. For Q3 2026, adjusted EBITDA is guided to $100–200 million, with Chemicals expected relatively flat sequentially, Winchester modestly improved, and corporate costs a sequential headwind. For 2026, capex is ~$200 million, cash taxes are cash-free plus or minus $20 million, year-end leverage is approximately 4.5x, and Beyond250 savings are expected above $100 million.
Trajectory
Reported revenue rose from $1,583.0 million in Q1 2026 to $1,741.9 million in Q2 2026, a 10.0% sequential increase. Reported gross margin widened from 5.0% to 9.8%, and reported EBITDA margin from 3.6% to 10.9%. The Q2 step-up was driven by caustic soda and EDC export pricing, stronger merchant chlorine, and the best epoxy result in more than three years, partially offset by the Freeport VCM outage.
The Model
The model projects FY+1 revenue of $6,923 million and EBITDA of $630 million, a 9.1% margin. FY+2 revenue is projected at $7,200 million with EBITDA of $792 million, an 11.0% margin. The near-term projection remains below management's stated normalized earnings, while the FY+2 step-up reflects the continued recovery and cost-out path described in the source material.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $6.8B | $6.9B | $7.2B |
| YoY Growth | — | +2.1% | +4.0% |
| EBITDA | $538M | $630M | $792M |
| EBITDA Margin | 7.9% | 9.1% | 11.0% |
Projections are the median of 5 independent model runs. The model’s revenue sits 1.1% below analyst consensus.
Management provided no annual EBITDA outlook. For Q3 2026, adjusted EBITDA is guided to $100–200 million, with Chemicals expected relatively flat sequentially, Winchester modestly improved, and corporate costs a sequential headwind. For 2026, capex is ~$200 million, cash taxes are cash-free plus or minus $20 million, year-end leverage is approximately 4.5x, and Beyond250 savings are expected above $100 million.
What Could Go Right — and Wrong
- Q4 export caustic/EDC pricing stabilizes above pre-conflict levels and product availability tightens as management expects.
- Freeport VCM returns to full capacity by end of Q3 2026, allowing Q4 to capture the outage reversal.
- Huntsman shareholder approval clears and the merger closes in H1 2027, starting the $400 million synergy capture.
- Epoxy remains profitable through the Q3 FIFO headwind, indicating the recent inflection is structural.
- Winchester exceeds its $30 million cost-out target after the Lake City assessment.
- Supply-disruption unwind is faster than expected, pulling Q3 adjusted EBITDA toward the low end of $100–200 million.
- Underlying housing and automotive demand weakens further, extending the earnings trough.
- Freeport reliability issues continue beyond Q3, adding unplanned maintenance costs.
- Huntsman deal stalls or fails shareholder vote, leaving leverage and litigation overhang without the planned transformation.
- Legacy litigation payments and working capital keep net debt rising, pushing leverage above the roughly 4.5x guide.
Looking Ahead
The next twelve months turn on the Huntsman merger, Q3 digestion, and whether Q4 tightens as management expects. The shareholder vote is August 25, 2026, with closing expected in first half 2027; Freeport VCM is expected back to full capacity by end of Q3 2026, and Chemours' long-term supply agreement begins in 2028.
- Aug 25, 2026Huntsman shareholder vote — Tests merger deal support before expected H1 2027 close.
- Q3 2026Q3 adjusted EBITDA print — Tests $100–200M guide with Chemicals flat and Epoxy positive.
- End of Q3 2026Freeport VCM full capacity — Tests Q4 recovery and reversal of outage impact.
- Q4 2026Export caustic/EDC pricing — Tests whether Q4 product availability tightens as management expects.
- H1 2027Huntsman merger close — Tests regulatory approval and start of $400M synergy capture.
- 2028Chemours supply agreement starts — Tests disclosed contract visibility and accretive demand.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $6.5B | $6.8B | $6.7B | +3.7% |
| Gross Margin | 11.3% | 7.4% | 6.9% | 390bps |
| EBITDA | $815M | $538M | $10.8B | -33.9% |
| EBITDA Margin | 12.5% | 7.9% | 6.6% | 452bps |
| Net Income | $109M | −$43M | −$139M | -139.2% |
| Free Cash Flow | $308M | $248M | $5.8B | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)6.9%
- EBITDA Margin (TTM)6.6%
- Net Margin (TTM)-2.1%
- ROIC-0.9%
- FCF Conversion1.9%
- SBC / Revenue0.2%
The Company
Olin Corporation is a vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The 2025 sales mix is Chlor Alkali Products and Vinyls at 54%, Epoxy at 20%, and Winchester at 26%. Chlorine, caustic soda, and hydrogen are co-produced by electrolysis of salt at a fixed ratio of 1.0 ton chlorine to 1.1 tons caustic soda to 0.03 tons hydrogen, so Olin manages the electrochemical unit and derivative values rather than any single chemical price.
Olin operates three capital-intensive manufacturing segments and a U.S. Gulf Coast asset base management frames as structurally advantaged after the Middle East conflict. It uses a 'value-first' commercial approach, managing operating rates to preserve ECU values rather than chasing volume, and is executing the Beyond250 structural cost program targeting more than $250 million in cumulative savings by 2028.
Business Segments
Competitive Landscape
Olin's FY2025 10-K lists OxyChem, Westlake Chemical, Formosa USA, and Shintech among North American chlor-alkali competitors, and Westlake, Huntsman, Kukdo, and Kumho among epoxy competitors. Winchester competes with The Kinetic Group. Huntsman has moved from named epoxy competitor to planned merger of equals partner.
- OxyChemNamed in 10-K as chlor-alkali competitor; former Occidental subsidiary sold to Berkshire Hathaway in January 2026.
- Westlake Chemical CorporationNamed in 10-K as chlor-alkali and epoxy competitor.
- Shintech IncorporatedNamed in 10-K as chlor-alkali competitor; also a legacy litigation counterparty.
- Named in 10-K as epoxy competitor; now planned merger of equals partner with close expected H1 2027.
- The Kinetic GroupNamed in 10-K as Winchester competitor; purchased from Vista Outdoor by Czechoslovak Group in November 2024.
Supply Chain
Olin operates as an integrated chlor-alkali and epoxy producer, and its Epoxy formulated solutions portfolio is focused on electronics, semiconductors, and power generation; Winchester serves ammunition demand. No provided neighbor transcript mentions Olin by name; the ecosystem read-throughs are inferred.
More on OLN: Earnings recap